FDA Adverse Event Malfunction Summary report: N

AXIUM PRIME BRPL 3D

MDR report key: 21394692 · Received February 18, 2025

Report

Report Number
9617601-2025-00177
Event Type
Malfunction
Date Received
February 18, 2025
Date of Event
February 13, 2025
Report Date
May 1, 2025
Manufacturer
MEDTRONIC MEXICO S. DE R.L. DE CV
Product Code
KRD
UDI-DI
00763000313760
PMA / PMN Number
K151447
Adverse Event
Yes
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
CH
Reporter Occupation
PHYSICIAN
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

CONTINUATION OF D10: PRODUCT ID UNK-NV-SAB (LOT: UNKNOWN); IMPLANT DATE N/A; EXPLANT DATE N/A. MEDTRONIC SUBMITS THIS REPORT TO COMPLY WITH FDA REGULATIONS 21 CFR PARTS 4 AND 803. MEDTRONIC HAS MADE REASONABLE EFFORTS TO PROVIDE AS MUCH RELEVANT INFORMATION AS IS AVAILABLE TO THE COMPANY AS OF THE SUBMISSION DATE OF THIS REPORT. THIS REPORT DOES NOT CONSTITUTE AN ADMISSION OR A CONCLUSION BY FDA, MEDTRONIC, OR ITS EMPLOYEES THAT THE DEVICE, MEDTRONIC, OR ITS EMPLOYEE CAUSED OR CONTRIBUTED TO THE EVENT DESCRIBED IN THE REPORT. ANY REQUIRED FIELDS THAT ARE UNPOPULATED ARE BLANK BECAUSE THE INFORMATION IS CURRENTLY UNKNOWN OR UNAVAILABLE. MEDTRONIC WILL SUBMIT A SUPPLEMENTAL REPORT IF ADDITIONAL RELEVANT INFORMATION BECOMES KNOWN.

Additional Manufacturer Narrative · 0

MEDTRONIC SUBMITS THIS REPORT TO COMPLY WITH FDA REGULATIONS 21 CFR PARTS 4 AND 803. MEDTRONIC HAS MADE REASONABLE EFFORTS TO PROVIDE AS MUCH RELEVANT INFORMATION AS IS AVAILABLE TO THE COMPANY AS OF THE SUBMISSION DATE OF THIS REPORT. THIS REPORT DOES NOT CONSTITUTE AN ADMISSION OR A CONCLUSION BY FDA, MEDTRONIC, OR ITS EMPLOYEES THAT THE DEVICE, MEDTRONIC, OR ITS EMPLOYEE CAUSED OR CONTRIBUTED TO THE EVENT DESCRIBED IN THE REPORT. ANY REQUIRED FIELDS THAT ARE UNPOPULATED ARE BLANK BECAUSE THE INFORMATION IS CURRENTLY UNKNOWN OR UNAVAILABLE. MEDTRONIC WILL SUBMIT A SUPPLEMENTAL REPORT IF ADDITIONAL RELEVANT INFORMATION BECOMES KNOWN.

Additional Manufacturer Narrative · 0

B5 UPDATED WITH ADDITIONAL INFORMATION RECEIVED. H3. DEVICE HAS BEEN RETURNED TO MEDTRONIC POSSESSION. COMPLETION OF ANALYSIS IS PENDING. MEDTRONIC SUBMITS THIS REPORT TO COMPLY WITH FDA REGULATIONS 21 CFR PARTS 4 AND 803. MEDTRONIC HAS MADE REASONABLE EFFORTS TO PROVIDE AS MUCH RELEVANT INFORMATION AS IS AVAILABLE TO THE COMPANY AS OF THE SUBMISSION DATE OF THIS REPORT. THIS REPORT DOES NOT CONSTITUTE AN ADMISSION OR A CONCLUSION BY FDA, MEDTRONIC, OR ITS EMPLOYEES THAT THE DEVICE, MEDTRONIC, OR ITS EMPLOYEE CAUSED OR CONTRIBUTED TO THE EVENT DESCRIBED IN THE REPORT. ANY REQUIRED FIELDS THAT ARE UNPOPULATED ARE BLANK BECAUSE THE INFORMATION IS CURRENTLY UNKNOWN OR UNAVAILABLE. MEDTRONIC WILL SUBMIT A SUPPLEMENTAL REPORT IF ADDITIONAL RELEVANT INFORMATION BECOMES KNOWN.

Additional Manufacturer Narrative · 0

H3: PRODUCT ANALYSIS AS FOUND CONDITION: THE AXIUM PRIME DEVICE WAS RETURNED FOR ANALYSIS WITHIN A SHIPPING BOX AND WITHIN A SEALED PLASTIC BIOHAZARD POUCH. THE ECHELON-10 MICRO CATHETER AND SOLITAIRE AB STENT USED IN THE EVENT WAS NOT RETURNED FOR ANALYSIS. VISUAL INSPECTION/DAMAGE LOCATION DETAILS: THE ACTUATOR INTERFACE WAS FOUND SECURELY ATTACHED TO THE COUPLER TUBE. THE BREAK INDICATOR WAS FOUND UNBROKEN. THE AXIUM PRIME PUSHER WAS FOUND BENT AT ~136.0CM FROM THE PROXIMAL END. THE COIN WAS FOUND STILL AGAINST THE LUMEN STOP, THE SHIELD COIL WAS FOUND UNDAMAGED, AND THE IMPLANT COIL WAS FOUND SEPARATED FORM THE DETACH ELEMENT AT THE COIL SHELL WELD. TESTING/ANALYSIS: N/A CONCLUSION: BASED ON THE DEVICE ANALYSIS AND REPORTED INFORMATION, THE CUSTOMER¿S REPORT OF ¿COIL LOOP IN PARENT VESSEL¿ TYPICALLY COULD NOT BE CONFIRMED THROUGH DEVICE ANALYSIS. CUSTOMER REPORTED THE SOLITAIRE AB STENT DID NOT COVER THE ANEURISM NECK IDEALLY, LIKELY ALLOWING THE IMPLANT ENDS TO ENTER THE VESSEL FROM THE ANEURISM. POSSIBLE CONTRIBUTORS ARE VESSEL TORTUOSITY, CATHETER TIP UNDER STRESS, CATHETER PLACEMENT OR CATHETER KICKBACK. CUSTOMER REPORTED VESSEL TORTUOSITY AS SEVERE AND THE MICRO CATHETER TIP WAS FOUND DAMAGED AFTER REMOVAL, WHICH POTENTIALLY CONTRIBUTE TOWARDS THE EVENT. THE CUSTOMER REPORT OF ¿PREMATURE DETACH¿ WAS CONFIRMED. THE CAUSE OF THE PREMATURE DETACH WAS DUE TO THE IMPLANT BREAK FOUND. IT IS POSSIBLE THE BREAK OCCURRED DUE TO THE DIFFICULTIES WITH PLACEMENT, CAUSING THE IMPLANT TO ENTANGLE WITH OTHER COILS (IF ANY) ALREADY IN THE ANEURISM OR WITH THE SOLITAIRE STENT, CAUSING THE COIL TO BREAK WHEN ATTEMPTING TO RETRIEVE. MEDTRONIC SUBMITS THIS REPORT TO COMPLY WITH FDA REGULATIONS 21 CFR PARTS 4 AND 803. MEDTRONIC HAS MADE REASONABLE EFFORTS TO PROVIDE AS MUCH RELEVANT INFORMATION AS IS AVAILABLE TO THE COMPANY AS OF THE SUBMISSION DATE OF THIS REPORT. THIS REPORT DOES NOT CONSTITUTE AN ADMISSION OR A CONCLUSION BY FDA, MEDTRONIC, OR ITS EMPLOYEES THAT THE DEVICE, MEDTRONIC, OR ITS EMPLOYEE CAUSED OR CONTRIBUTED TO THE EVENT DESCRIBED IN THE REPORT. ANY REQUIRED FIELDS THAT ARE UNPOPULATED ARE BLANK BECAUSE THE INFORMATION IS CURRENTLY UNKNOWN OR UNAVAILABLE. MEDTRONIC WILL SUBMIT A SUPPLEMENTAL REPORT IF ADDITIONAL RELEVANT INFORMATION BECOMES KNOWN.

Description of Event or Problem · 0

MEDTRONIC RECEIVED A REPORT THAT AN AXIUM COIL PREMATURELY DETACHED. THE PATIENT WAS UNDERGOING SURGERY FOR TREATMENT OF A SACCULAR, UNRUPTURED ANEURYSM OF THE RIGHT POSTERIOR COMMUNICATING ARTERY WITH A MAX DIAMETER OF 4MM AND A 3MM NECK DIAMETER. IT WAS NOTED THE PATIENT'S BLOOD FLOW WAS NORMAL AND VESSEL TORTUOSITY WAS SEVERE. IT WAS REPORTED THAT WHEN EMBOLIZING WITH A NORMAL HYDRATED COIL, THE SOLITAIRE AB STENT DID NOT COVER THE ANEURYSM NECK IDEALLY, AND ONE OR TWO EDGES OF THE COIL BULGED INTO THE NORMAL BLOOD VESSEL DURING THE EMBOLIZATION PROCESS. AFTER REPEATED ADJUSTMENTS, THE SITUATION REMAINED THE SAME, SO IT WAS PLANNED TO RETRIEVE THE SPRING COIL, RETRIEVE THE AB STENT, AND THEN DEPLOY THE STENT AGAIN. HOWEVER, DURING THE PROCESS OF RETRIEVING THE SPRING COIL, THE SPRING COIL WAS DETACHED PREMATURELY AND DID NOT TOUCH THE DETACHMENT AREA AT THE TAIL END OF THE PUSHER. THE COIL WAS REMOVED FROM THE PATIENT WITH THE SAB STENT. THE SAB STENT AND ECHELON WERE THEN WITHDRAWN INTO THE INTERMEDIATE CATHETER AND REMOVED FROM THE BODY. THE CATHETER WAS THEN RE-INSERTED AND THE SURGERY CONTINUED. THERE WAS NO SURGICAL OR MEDICINAL INTERVENTION REQUIRED. THE PUSHWIRE WAS NOT BENT OR BROKEN. THERE WAS NO FRICTION OR DIFFICULTY DUR ING DELIVERY. THE PHYSICIAN REPOSITIONED THE COIL 3 TIMES. THE PHYSICIAN DID NOT ATTEMPT TO DETACH THE COIL AND DID NOT ROTATE THE DELIVERY PUSHER DURING THE PROCEDURE. CONTINUOUS FLUSH WAS ADMINISTERED DURING THE PROCEDURE. THE REPORTED DEVICE AND ANY ACCESSORY DEVICES WERE PREPARED AS INDICATED IN THE INSTRUCTIONS FOR USE (IFU). NO PATIENT SYMPTOMS OR COMPLICATIONS WERE ASSOCIATED WITH THIS EVENT.

Description of Event or Problem · 0

ADDITIONAL INFORMATION RECEIVED REPORTED THE CAUSE OF THE COIL PREMATURE DETACHMENT/COIL LOOP IN PARENT VESSEL COULD NOT BE DETERMINED.

Description of Event or Problem · 0

ADDITIONAL INFORMATION RECEIVED REPORTED THERE WAS NO OBVIOUS RESISTANCE DURING DELIVERY OF THE COIL IN THE ECHELON CATHETER. HOWEVER, DURING DELIVERY, THE COIL APPEARED TO BE COMING OUT FROM THE TIP MARKER LOCATION AND IT WAS SUSPECTED THE TIP OF THE CATHETER WAS DAMAGED. WHEN THE SYSTEM WAS REMOVED AS A WHOLE, THERE WAS HOLE.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1168563 AXIUM PRIME BRPL 3D DEVICE, VASCULAR, FOR PROMOTING EMBOLIZATION KRD MEDTRONIC MEXICO S. DE R.L. DE CV APB-3.5-8-3D-ES 229294044 00763000313760

Patients

Seq Age Sex Outcome Treatment
1 78 YR Female